Loss of Smell – Page 5 – Communicable Diseases Research

SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report

Pediatrics

Published on 2022-01-142022-10-31
Journal: Frontiers in Pediatrics [Category] COVID-19,

[키워드] activating acute respiratory syndrome addition Adolescent anti-SARS-CoV-2 applied autoantibody B cell B-cell Case report CD21 chronic graft vs. host disease clearance of SARS-CoV-2 Combination Complete complex Computed tomography coronavirus cough Course COVID-19 diagnosed disease Donor EBV elevated Evolution expression Extracorporeal photopheresis HSCT humoral immune response ill patient immune immune dysregulation immunodeficiency immunological immunomodulatory Infection infectious complication Laboratory test Loss of Smell Luck lymphopenia Macrophage male mechanism moderate monoclonal antibody Mortality other immunosuppressive agents oxygen saturation parameter Patient Prednisone regimen Remdesivir report resolution of symptoms risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific antibody severe disease course Standard Stem cell transplantation steroid supportive care syndrome T-cell immunity the patient transaminitis treated Treatment Viraemia virus
[DOI] 10.3389/fped.2021.775318 PMC 바로가기 [Article Type] Pediatrics

Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study

Original Article

Published on 2022-01-092022-10-31
Journal: European journal of pediatrics [Category] COVID-19, COVID19(2023년), SARS,

In Search of a Neurotologic Profile in COVID-19 — A Study in Health Care Workers

Otolaryngology

Published on 2022-01-072022-10-31
Journal: Cureus [Category] COVID-19,

Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19

COVID-19의 발달에서 숙주의 면역 다형성 및 SARS-COV-2의 유전 적 가변성의 의미

Review

Published on 2022-01-062022-09-10
Journal: Viruses [Category] SARS, 변종,

[키워드] ACE2 ACE2 overexpression acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 affecting agent angiotensin Angiotensin-converting enzyme binding Characteristics claimed Clinical signs coagulation disorders coronavirus coronavirus disease Coronavirus-2 country COVID-19 develop development dry cough Epigenetic explain Factor Fever Genetic genetic factors genetic susceptibility headache immune polymorphism immune system Immunopathogenesis include increment infection rate involved Loss of Smell loss of smell or taste molecules Most patients pandemic patients polymorphism respiratory responsible SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 severe COVID-19 severe pneumonia Symptoms Taste Variability Viral viral entry viral infection
[DOI] 10.3390/v14010094 PMC 바로가기 [Article Type] Review

Clinical Presentation of the SARS-CoV-2 Virus Infection and Predictive Validity of the PCR Test in Primary Health Care Worker Patients of the Spanish National Health System

Article

Published on 2022-01-042022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Public awareness of the neurological manifestation of COVID-19 in Saudi Arabia

사우디아라비아에서 COVID-19의 신경학적 징후에 대한 대중의 인식

Case Reports

Published on 2022-01-012022-09-11
Journal: Neurosciences (Riyadh, Saudi Arabia) [Category] SARS, 치료기술,

Clinical Management of COVID-19 Patients – An Update

Review article

Published on 2022-01-012022-10-05
Journal: Seminars in nuclear medicine [Category] SARS, 치료제,

[키워드] anticoagulation antivirals be worn blood sample cause chest X-ray clinical Cognitive impairment Contact COVID-19 COVID-19 disease CT scan determine Diagnosis drug Dyspnea evaluated fatigue ground-glass opacity Health healthy individual Hospitalization hospitals imaging Immunocompromised patients include indications laboratory-confirmed Loss of Smell Mental Mild mild-to-moderate disease monoclonal antibody Mortality organ system outpatient clinic Oxygen therapy patchy Patient patients PCR physical plasma Population PPE receiving rehabilitation reported reported symptom SARS-CoV-2 RNA SARS-CoV-2 virus severe COVID-19 severity Steroids suspected patient Symptom tested therapy treated Treatment
[DOI] 10.1053/j.semnuclmed.2021.06.004 [Article Type] Review article

Outcomes of Ayurvedic care in a COVID-19 patient with hypoxia – A case report

Case report

Published on 2022-01-012022-10-05
Journal: Journal of Ayurveda and Integrative Medicine [Category] 신약개발,

GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study

Research

Published on 2021-12-292022-10-28
Journal: The BMJ [Category] COVID-19, Fulltext, SARS,

[키워드] 95% confidence interval abdominal pain adjusted hazard ratio Analysis Anxiety Asthma Aurum breathlessness Chest clinical Cognitive impairment cohorts Community contributing to Cox regression database Depression described determine Diagnosis diarrhoea disease Diseases dose England first vaccination Follow-up healthcare hospital individual Infection Influenza Ischaemic heart disease joint Loss of Smell Lung fibrosis median age nausea negative control neuropathic non-steroidal anti-inflammatory drug objective outcome outcome measure Pain pandemic Paracetamol participant Patient patients with influenza Population Practice proportions Rate reduced relative renal repeated Result setting significantly higher symptomatic Symptoms vaccination Venous Thromboembolism
[DOI] 10.1136/bmj-2021-065834 PMC 바로가기 [Article Type] Research

Clinical Sensitivity, Specificity and Epidemiology of SARS-CoV-2 Serological Testing Using the Biozek COVID-19 Test

Article

Published on 2021-12-282022-10-31
Journal: Diagnostics [Category] COVID-19,